Latest Anal cancer Stories
NORTH BRUNSWICK, N.J., May 28, 2015 /PRNewswire/ -- PDS Biotechnology Corp.
Helps Protect Against Nine HPV types - Including Types that Cause About 90% of Cervical Cancer Cases KIRKLAND, QC, April 1, 2015 /CNW Telbec/ - Merck (NYSE: MRK), known as MSD outside
RnRMarketResearch.com adds "Anal Cancer - Pipeline Review, H2 2014" to its store. This report provides an overview of the Anal Cancer's therapeutic pipeline. DALLAS, Jan.
A Japanese mushroom extract appears to be effective for the eradication of human papillomavirus , according to a pilot clinical trial at The University of Texas Health Science Center at Houston Medical School.
Lesscancer.org Board member Margaret I. Cuomo, M. D.
A long-term follow-up study (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity and safety of GlaxoSmithKline's human papilloma virus (HPV) vaccine Cervarix. Women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine were followed for more than nine years, and vaccine efficacy (VE) against incident infection was 100%.
Grant Earmarked for Trial Drug Aimed at Treatment of Anal Cancer LOS ANGELES, April 30, 2014 /PRNewswire/ -- The Farrah Fawcett Foundation (FFF) has presented a $50,000 grant
LONDON, April 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Researchers at the University of Texas Medical Branch at Galveston are the first to recommend that young women treated with radiation for cervical cancer should begin colorectal cancer screening earlier than traditionally recommended.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.